Market
Primary regulatory outcome for Alcon post-Systane recall by end of 2025?
2
Resolution / Starting Odds
Fine imposed • 25%
Mandatory product reformulation • 25%
Temporary production halt • 25%
No further action • 25%
FDA announcements and official regulatory documents
Story
Alcon Recalls Systane Eye Drops That May Cause Vision Damage Due to Fungal Contamination
Dec 24, 2024, 06:30 PM
Alcon Laboratories has issued a nationwide recall of certain Systane brand eye drops due to potential fungal contamination that may cause vision damage. The recall affects a single lot of 'Systane Lubricant Eye Drops Ultra SPF, Single Vials On-the-Go' after a consumer reported finding a foreign material in a sealed vial. Upon investigation, the material was identified as fungal. The U.S. Food and Drug Administration announced the voluntary recall, advising consumers to check their medicine cabinets and discontinue use of the affected product.
View original story
Similar markets
Other outcome • 25%
Alcon loses market share • 25%
Alcon gains market share • 25%
No significant change • 25%
No issues found • 25%
Minor compliance issues • 25%
Major compliance issues • 25%
Recall expanded • 25%
Increased quality checks • 25%
Product reformulation • 25%
Discontinue product • 25%
No significant changes • 25%
Decrease by more than 10% • 25%
Increase by more than 10% • 25%
Other outcome • 25%
No significant change (+/- 10%) • 25%
Supply chain contamination • 25%
No specific cause identified • 25%
Other cause • 25%
Manufacturing defect • 25%
CVS • 25%
Walgreens • 25%
Other • 25%
Target • 25%